BONNIE KWAN: Open Payments
NPI 1891294732 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,489 in 151 payments from 18 companies in 2025. Trend: 2023 $4,385 · 2024 $5,795 · 2025 $9,489
Food & beverage: $4,201Consulting: $4,135Travel & lodging: $1,153
| Company | Payments | Amount |
|---|---|---|
| Organon LLC | 16 | $3,898 |
| Arcutis Biotherapeutics, Inc. | 25 | $1,557 |
| UCB, Inc. | 15 | $1,281 |
| GENZYME CORPORATION | 9 | $562 |
| Janssen Biotech, Inc. | 14 | $295 |
| ABBVIE INC. | 13 | $288 |
| Galderma Laboratories, L.P. | 9 | $274 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $243 |
| LEO Pharma Inc. | 7 | $218 |
| Novartis Pharmaceuticals Corporation | 5 | $151 |
Products named: VTAMA, Zoryve, Bimzelx, DUPIXENT, TREMFYA, Winlevi, ADBRY, AKLIEF.
Industry payments across NV — which companies pay providers there.
